Catalyst Pharmaceuticals (CPRX) Other Gross PP&E Adjustments (2011 - 2026)
Catalyst Pharmaceuticals posted quarterly Other Gross PP&E Adjustments of -$30.0 million for Q1 2026, down 2.88% year-on-year from -$30.9 million in Q1 2025, and down 177.17% on a QoQ basis from -$10.8 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 16 years of Other Gross PP&E Adjustments data on file, last reported at -$30.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 2.88% year-over-year to -$30.0 million; the trailing twelve-month figure through Mar 2026 stood at -$30.0 million (down 2.88% YoY), and the FY2025 full-year result was -$10.8 million, up 11.28% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$30.0 million, down from -$10.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$1.4 million in Q1 2024 and bottomed at -$30.0 million in Q1 2026.
- The 5-year median for Other Gross PP&E Adjustments is -$6.2 million (2023), against an average of -$9.9 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments soared 39.09%; it then sank 1911.11% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$2.8 million in 2022, then tumbled by 125.52% to -$6.2 million in 2023, then tumbled by 95.15% to -$12.2 million in 2024, then gained by 11.28% to -$10.8 million in 2025, then tumbled by 177.17% to -$30.0 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$30.0 million (Q1 2026), -$10.8 million (Q4 2025), and -$10.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -29.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.98 Mn |
| Mar 31, 2026 | -29.98 Mn |
| Dec 31, 2025 | -10.82 Mn |
| Dec 31, 2025 | -10.82 Mn |
| Sep 30, 2025 | -10.28 Mn |
| Sep 30, 2025 | -10.28 Mn |
| Jun 30, 2025 | -20.34 Mn |
| Jun 30, 2025 | -20.34 Mn |
| Mar 31, 2025 | -29.14 Mn |
| Mar 31, 2025 | -29.14 Mn |
| Dec 31, 2024 | -12.19 Mn |
| Dec 31, 2024 | -12.19 Mn |
| Sep 30, 2024 | -10.66 Mn |
| Sep 30, 2024 | -10.66 Mn |
| Jun 30, 2024 | -20.36 Mn |
| Jun 30, 2024 | -20.36 Mn |
| Mar 31, 2024 | -1.45 Mn |
| Mar 31, 2024 | -1.45 Mn |
| Dec 31, 2023 | -6.25 Mn |
| Dec 31, 2023 | -6.25 Mn |
| Sep 30, 2023 | -2.14 Mn |
| Sep 30, 2023 | -2.14 Mn |
| Jun 30, 2023 | -2.59 Mn |
| Jun 30, 2023 | -2.59 Mn |
| Mar 31, 2023 | -2.27 Mn |
| Mar 31, 2023 | -2.27 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -1.85 Mn |
| Sep 30, 2022 | -1.85 Mn |
| Jun 30, 2022 | -2.84 Mn |
| Jun 30, 2022 | -2.84 Mn |
| Mar 31, 2022 | -2.91 Mn |
| Mar 31, 2022 | -2.91 Mn |
| Dec 31, 2021 | -2.97 Mn |
| Dec 31, 2021 | -2.97 Mn |
| Sep 30, 2021 | -3.04 Mn |
| Sep 30, 2021 | -3.04 Mn |
| Jun 30, 2021 | -3.07 Mn |
| Jun 30, 2021 | -3.07 Mn |
| Mar 31, 2021 | -3.18 Mn |
| Mar 31, 2021 | -3.18 Mn |
| Dec 31, 2020 | 177,000.00 |
| Dec 31, 2020 | 177,000.00 |
| Sep 30, 2020 | -12,167.00 |
| Sep 30, 2020 | -12,167.00 |
| Jun 30, 2020 | -71,711.00 |
| Jun 30, 2020 | -71,711.00 |
| Mar 31, 2020 | -730,284.00 |
| Mar 31, 2020 | -730,284.00 |
| Dec 31, 2019 | -793,252.00 |
| Dec 31, 2019 | -793,252.00 |
| Sep 30, 2019 | -670,695.00 |
| Sep 30, 2019 | -670,695.00 |
| Jun 30, 2019 | -731,945.00 |
| Jun 30, 2019 | -731,945.00 |
| Mar 31, 2019 | -803,232.00 |
| Mar 31, 2019 | -803,232.00 |
| Dec 31, 2018 | -868,489.00 |
| Dec 31, 2018 | -868,489.00 |
| Sep 30, 2018 | -43,326.00 |
| Sep 30, 2018 | -43,326.00 |
| Jun 30, 2018 | 24,393.00 |
| Jun 30, 2018 | 24,393.00 |
| Mar 31, 2018 | -207,706.00 |
| Mar 31, 2018 | -207,706.00 |
| Dec 31, 2017 | 123,097.00 |
| Dec 31, 2017 | 123,097.00 |
| Sep 30, 2017 | 246,872.00 |
| Sep 30, 2017 | 246,872.00 |
| Jun 30, 2017 | 227,450.00 |
| Jun 30, 2017 | 227,450.00 |
| Mar 31, 2017 | 233,031.00 |
| Mar 31, 2017 | 233,031.00 |
| Dec 31, 2016 | 255,011.00 |
| Dec 31, 2016 | 255,011.00 |
| Sep 30, 2016 | 350,554.00 |
| Sep 30, 2016 | 350,554.00 |
| Jun 30, 2016 | 350,554.00 |
| Jun 30, 2016 | 350,554.00 |
| Mar 31, 2016 | 261,623.00 |
| Mar 31, 2016 | 261,623.00 |
| Dec 31, 2015 | -68,867.00 |
| Dec 31, 2015 | -68,867.00 |
| Sep 30, 2015 | 188,536.00 |
| Sep 30, 2015 | 188,536.00 |
| Jun 30, 2015 | 101,464.00 |
| Jun 30, 2015 | 101,464.00 |
| Mar 31, 2015 | 43,338.00 |
| Mar 31, 2015 | 43,338.00 |
| Dec 31, 2014 | 140,597.00 |
| Dec 31, 2014 | 140,597.00 |
| Sep 30, 2014 | -24,789.00 |
| Sep 30, 2014 | -24,789.00 |
| Jun 30, 2014 | -60,821.00 |
| Jun 30, 2014 | -60,821.00 |
| Mar 31, 2014 | -79,733.00 |
| Mar 31, 2014 | -79,733.00 |
| Dec 31, 2013 | 15,834.00 |
| Dec 31, 2013 | 15,834.00 |
| Sep 30, 2013 | 17,260.00 |
| Sep 30, 2013 | 17,260.00 |
| Jun 30, 2013 | 36,504.00 |
| Jun 30, 2013 | 36,504.00 |
| Mar 31, 2013 | 34,951.00 |
| Mar 31, 2013 | 34,951.00 |
| Dec 31, 2012 | 72,592.00 |
| Dec 31, 2012 | 72,592.00 |
| Sep 30, 2012 | -31,910.00 |
| Sep 30, 2012 | -31,910.00 |
| Jun 30, 2012 | -6,000.00 |
| Jun 30, 2012 | -6,000.00 |
| Dec 31, 2011 | -40,660.00 |
| Dec 31, 2011 | -40,660.00 |